<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35711419</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection.</ArticleTitle><Pagination><StartPage>886611</StartPage><MedlinePgn>886611</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">886611</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.886611</ELocationID><Abstract><AbstractText>Rhinoviruses (RV) have been shown to inhibit subsequent infection by heterologous respiratory viruses, including influenza viruses and severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). To better understand the mechanisms whereby RV protects against pulmonary coronavirus infection, we used a native murine virus, mouse hepatitis virus strain 1 (MHV-1), that causes severe disease in the lungs of infected mice. We found that priming of the respiratory tract with RV completely prevented mortality and reduced morbidity of a lethal MHV-1 infection. Replication of MHV-1 was reduced in RV-primed mouse lungs although expression of antiviral type I interferon, IFN-β, was more robust in mice infected with MHV-1 alone. We further showed that signaling through the type I interferon receptor was required for survival of mice given a non-lethal dose of MHV-1. RV-primed mice had reduced pulmonary inflammation and hemorrhage and influx of leukocytes, especially neutrophils, in the airways upon MHV-1 infection. Although MHV-1 replication was reduced in RV-primed mice, RV did not inhibit MHV-1 replication in coinfected lung epithelial cells <i>in vitro</i>. In summary, RV-mediated priming in the respiratory tract reduces viral replication, inflammation, and tissue damage, and prevents mortality of a pulmonary coronavirus infection in mice. These results contribute to our understanding of how distinct respiratory viruses interact with the host to affect disease pathogenesis, which is a critical step in understanding how respiratory viral coinfections impact human health.</AbstractText><CopyrightInformation>Copyright © 2022 Cox, Gonzalez, Ijezie, Rodriguez, Miller, Van Leuven and Miura.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Garrison</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Andres J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Modeling Collaboration and Innovation, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ijezie</LastName><ForeName>Emmanuel C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Andres</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Craig R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Modeling Collaboration and Innovation, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Leuven</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Modeling Collaboration and Innovation, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miura</LastName><ForeName>Tanya A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Modeling Collaboration and Innovation, University of Idaho, Moscow, ID, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P20 GM104420</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM103397</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006517" MajorTopicYN="Y">Murine hepatitis virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronaviral infection</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">mouse hepatitis virus</Keyword><Keyword MajorTopicYN="N">mouse model</Keyword><Keyword MajorTopicYN="N">respiratory virus co-infection</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>17</Day><Hour>2</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35711419</ArticleId><ArticleId IdType="pmc">PMC9196734</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.886611</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yeoh DK, Foley DA, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. . Impact of Coronavirus Disease 2019 Public Health Measures on Detections of Influenza and Respiratory Syncytial Virus in Children During the 2020 Australian Winter. Clin Infect Dis (2021) 72:2199–202. doi: 10.1093/cid/ciaa1475</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1475</ArticleId><ArticleId IdType="pmc">PMC7543326</ArticleId><ArticleId IdType="pubmed">32986804</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley DA, Yeoh DK, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. . The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures. Clin Infect Dis (2021) 73:E2829–30. doi: 10.1093/cid/ciaa1906</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1906</ArticleId><ArticleId IdType="pmc">PMC7929151</ArticleId><ArticleId IdType="pubmed">33594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang X, Cong B, Deng S, Feikin DR, Nair H. Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the COVID-19 Pandemic. J Infect Dis (2022) 225:957–64. doi: 10.1093/infdis/jiab606/6507738</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab606/6507738</ArticleId><ArticleId IdType="pmc">PMC8807230</ArticleId><ArticleId IdType="pubmed">35030633</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Glass E, Hoang VT, Boschi C, Ninove L, Zandotti C, Boutin A, et al. . Incidence and Outcome of Coinfections With SARS-CoV-2 and Rhinovirus. Viruses (2021) 13:2528. doi: 10.3390/v13122528</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13122528</ArticleId><ArticleId IdType="pmc">PMC8709236</ArticleId><ArticleId IdType="pubmed">34960797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I, Artama M, Haapanen M, Renko M. Rhinovirus Spread in Children During the COVID-19 Pandemic Despite Social Restrictions—A Nationwide Register Study in Finland. J Med Virol (2021) 93:6063–7. doi: 10.1002/jmv.27180</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27180</ArticleId><ArticleId IdType="pmc">PMC8426983</ArticleId><ArticleId IdType="pubmed">34228369</ArticleId></ArticleIdList></Reference><Reference><Citation>Anestad G, Nordbo SA. Virus Interference. Did Rhinoviruses Activity Hamper the Progress of the 2009 Influenza A (H1N1) Pandemic in Norway? Med Hypotheses (2011) 77:1132–4. doi: 10.1016/j.mehy.2011.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2011.09.021</ArticleId><ArticleId IdType="pubmed">21975051</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalegno JS, Ottmann M, Duchamp MB, Escuret V, Billaud G, Frobert E, et al. . Rhinoviruses Delayed the Circulation of the Pandemic Influenza A (H1N1) 2009 Virus in France. Clin Microbiol Infect (2010) 16:326–9. doi: 10.1111/j.1469-0691.2010.03167.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2010.03167.x</ArticleId><ArticleId IdType="pubmed">20121829</ArticleId></ArticleIdList></Reference><Reference><Citation>Dee K, Goldfarb DM, Haney J, Amat JAR, Herder V, Stewart M, et al. . Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology. J Infect Dis (2021) 224:31–8. doi: 10.1093/infdis/jiab147</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab147</ArticleId><ArticleId IdType="pmc">PMC8083659</ArticleId><ArticleId IdType="pubmed">33754149</ArticleId></ArticleIdList></Reference><Reference><Citation>de Albuquerque N, Baig E, Ma X, Zhang J, He W, Rowe A, et al. . Murine Hepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice. J Virol (2006) 80:10382–94. doi: 10.1128/JVI.00747-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00747-06</ArticleId><ArticleId IdType="pmc">PMC1641767</ArticleId><ArticleId IdType="pubmed">17041219</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanolkar A, Fulton RB, Epping LL, Pham N-L, Tifrea D, Varga SM, et al. . T Cell Epitope Specificity and Pathogenesis of Mouse Hepatitis Virus-1–Induced Disease in Susceptible and Resistant Hosts. J Immunol (2010) 185:1132–41. doi: 10.4049/jimmunol.0902749</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0902749</ArticleId><ArticleId IdType="pmc">PMC2897948</ArticleId><ArticleId IdType="pubmed">20554960</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanolkar A, Hartwig SM, Haag BA, Meyerholz DK, Harty JT, Varga SM. Toll-Like Receptor 4 Deficiency Increases Disease and Mortality After Mouse Hepatitis Virus Type 1 Infection of Susceptible C3H Mice. J Virol (2009) 83:8946–56. doi: 10.1128/jvi.01857-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01857-08</ArticleId><ArticleId IdType="pmc">PMC2738158</ArticleId><ArticleId IdType="pubmed">19553337</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanolkar A, Hartwig SM, Haag BA, Meyerholz DK, Epping LL, Haring JS, et al. . Protective and Pathologic Roles of the Immune Response to Mouse Hepatitis Virus Type 1: Implications for Severe Acute Respiratory Syndrome. J Virol (2009) 83:9258–72. doi: 10.1128/JVI.00355-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00355-09</ArticleId><ArticleId IdType="pmc">PMC2738266</ArticleId><ArticleId IdType="pubmed">19570864</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas MJ, Mohamed AB, Norenberg MD, Saad A, Barry AF, Colon C, et al. . Multi-Organ Histopathological Changes in a Mouse Hepatitis Virus Model of COVID-19. Viruses (2021) 13:1703. doi: 10.3390/v13091703</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091703</ArticleId><ArticleId IdType="pmc">PMC8473123</ArticleId><ArticleId IdType="pubmed">34578284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez AJ, Ijezie EC, Balemba OB, Miura TA. Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model. J Virol (2018) 92:e00881-18. doi: 10.1128/JVI.00881-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00881-18</ArticleId><ArticleId IdType="pmc">PMC6232468</ArticleId><ArticleId IdType="pubmed">30232180</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Leuven JT, Gonzalez AJ, Ijezie EC, Wixom AQ, Clary JL, Naranjo MN, et al. . Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms. mSphere (2021) 6:e00479-21. doi: 10.1128/mSphere.00479-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00479-21</ArticleId><ArticleId IdType="pmc">PMC8265665</ArticleId><ArticleId IdType="pubmed">34160242</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council (U.S.) . Committee for the Update of the Guide for the Care and Use of Laboratory Animals. In: Guide for the Care and Use of Laboratory Animals. 8th ed. Washington DC: National Academies Press; (2011). 220 p.</Citation><ArticleIdList><ArticleId IdType="pubmed">21595115</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-Lambda (IFN-Lambda) is Expressed in a Tissue-Dependent Fashion and Primarily Acts on Epithelial Cells In Vivo . PloS Pathog (2008) 4:e1000017. doi: 10.1371/journal.ppat.1000017</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000017</ArticleId><ArticleId IdType="pmc">PMC2265414</ArticleId><ArticleId IdType="pubmed">18369468</ArticleId></ArticleIdList></Reference><Reference><Citation>Moltedo B, Li W, Yount JS, Moran TM. Unique Type I Interferon Responses Determine the Functional Fate of Migratory Lung Dendritic Cells During Influenza Virus Infection. PloS Pathog (2011) 7:e1002345. doi: 10.1371/journal.ppat.1002345</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002345</ArticleId><ArticleId IdType="pmc">PMC3207893</ArticleId><ArticleId IdType="pubmed">22072965</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PH, Mehta HV, Maric M, Roller RJ, Okeoma CM. Bone Marrow Stromal Cell Antigen 2 (BST-2) Restricts Mouse Mammary Tumor Virus (MMTV) Replication. vivo. Retrovirol (2012) 9:10. doi: 10.1186/1742-4690-9-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-9-10</ArticleId><ArticleId IdType="pmc">PMC3283513</ArticleId><ArticleId IdType="pubmed">22284121</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-ΔΔC(T)) Method. Methods (2001) 25:402–8. doi: 10.1006/meth.2001.1262</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Leuven JT, Ridenhour BJ, Gonzalez AJ, Miller CR, Miura TA. Lung Epithelial Cells Have Virus-Specific and Shared Gene Expression Responses to Infection by Diverse Respiratory Viruses. PloS One (2017) 12 e0178408. doi: 10.1371/journal.pone.0178408</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178408</ArticleId><ArticleId IdType="pmc">PMC5456070</ArticleId><ArticleId IdType="pubmed">28575086</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua X, Vijay R, Channappanavar R, Athmer J, Meyerholz DK, Pagedar N, et al. . Nasal Priming by a Murine Coronavirus Provides Protective Immunity Against Lethal Heterologous Virus Pneumonia. JCI Insight (2018) 3:e99025. doi: 10.1172/jci.insight.99025</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.99025</ArticleId><ArticleId IdType="pmc">PMC6124400</ArticleId><ArticleId IdType="pubmed">29875310</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig SM, Miller AM, Varga SM. Respiratory Syncytial Virus Provides Protection Against a Subsequent Influenza A Virus Infection. J Immunol (2022) 208:720–31. doi: 10.4049/jimmunol.2000751</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000751</ArticleId><ArticleId IdType="pmc">PMC8851717</ArticleId><ArticleId IdType="pubmed">35022269</ArticleId></ArticleIdList></Reference><Reference><Citation>George JA, Alshamsi SH, Alhammadi MH, Alsuwaidi AR. Exacerbation of Influenza a Virus Disease Severity by Respiratory Syncytial Virus Co-Infection in A Mouse Model. Viruses (2021) 13:1630. doi: 10.3390/v13081630</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081630</ArticleId><ArticleId IdType="pmc">PMC8402720</ArticleId><ArticleId IdType="pubmed">34452495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AJ, Lee ACY, Chan JFW, Liu F, Li C, Chen Y, et al. . Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters. Clin Infect Dis (2021) 72:E978–92. doi: 10.1093/cid/ciaa1747</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1747</ArticleId><ArticleId IdType="pmc">PMC7717201</ArticleId><ArticleId IdType="pubmed">33216851</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfmann PJ, Nakajima N, Sato Y, Takahashi K, Accola M, Chiba S, et al. . SARS-Cov-2 Interference of Influenza Virus Replication in Syrian Hamsters. J Infect Dis (2022) 225:282–6. doi: 10.1093/infdis/jiab587</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab587</ArticleId><ArticleId IdType="pmc">PMC8689717</ArticleId><ArticleId IdType="pubmed">34875072</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Skarlupka AL, Jang H, Blas-Machado U, Holladay N, Hogan RJ, et al. . SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets. J Virol (2021) 96:e01791-21. doi: 10.1128/jvi.01791-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01791-21</ArticleId><ArticleId IdType="pmc">PMC8906421</ArticleId><ArticleId IdType="pubmed">34936487</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai L, Zhao Y, Dong J, Liang S, Guo M, Liu X, et al. . Coinfection With Influenza A Virus Enhances SARS-CoV-2 Infectivity. Cell Res (2021) 31:395–403. doi: 10.1038/s41422-021-00473-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00473-1</ArticleId><ArticleId IdType="pmc">PMC7890106</ArticleId><ArticleId IdType="pubmed">33603116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L, Deng W, Qi F, Lv Q, Song Z, Liu J, et al. . Sequential Infection With H1N1 and SARS-CoV-2 Aggravated COVID-19 Pathogenesis in a Mammalian Model, and Co-Vaccination as an Effective Method of Prevention of COVID-19 and Influenza. Signal Transduct Target Ther (2021) 6:200. doi: 10.1038/s41392-021-00618-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00618-z</ArticleId><ArticleId IdType="pmc">PMC8134832</ArticleId><ArticleId IdType="pubmed">34016949</ArticleId></ArticleIdList></Reference><Reference><Citation>Achdout H, Vitner EB, Politi B, Melamed S, Yahalom-Ronen Y, Tamir H, et al. . Increased Lethality in Influenza and SARS-CoV-2 Coinfection Is Prevented by Influenza Immunity But Not SARS-CoV-2 Immunity. Nat Commun (2021) 12:5819. doi: 10.1038/s41467-021-26113-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26113-1</ArticleId><ArticleId IdType="pmc">PMC8492774</ArticleId><ArticleId IdType="pubmed">34611155</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E-H, Nguyen T-Q, Casel MAB, Rollon R, Kim S, Kim Y-I, et al. . Coinfection With SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impaires Neutralizing Antibody and CD4+ T Cell Responses. J Virol (2022) 96:e01873-21. doi: 10.1128/jvi.01873-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01873-21</ArticleId><ArticleId IdType="pmc">PMC8941868</ArticleId><ArticleId IdType="pubmed">35107382</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett NW, Walton RP, Edwards MR, Aniscenko J, Caramori G, Zhu J, et al. . Mouse Models of Rhinovirus-Induced Disease and Exacerbation of Allergic Airway Inflammation. Nat Med (2008) 14:199–204. doi: 10.1038/nm1713</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1713</ArticleId><ArticleId IdType="pmc">PMC3384678</ArticleId><ArticleId IdType="pubmed">18246079</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger BL, Faris AN, Ganesan S, Comstock AT, Hershenson MB, Sajjan US. Rhinovirus Attenuates non-Typeable Hemophilus Influenzae-Stimulated IL-8 Responses Via TLR2-dependent Degradation of IRAK-1. PloS Pathog (2012) 8:e1002969. doi: 10.1371/journal.ppat.1002969</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002969</ArticleId><ArticleId IdType="pmc">PMC3464227</ArticleId><ArticleId IdType="pubmed">23055935</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan S, Pham D, Jing Y, Farazuddin M, Hudy MH, Unger B, et al. . Tlr2 Activation Limits Rhinovirus-Stimulated Cxcl-10 by Attenuating Irak-1-Dependent IL-33 Receptor Signaling in Human Bronchial Epithelial Cells. J Immunol (2016) 197:2409–20. doi: 10.4049/jimmunol.1502702</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1502702</ArticleId><ArticleId IdType="pmc">PMC5070654</ArticleId><ArticleId IdType="pubmed">27503209</ArticleId></ArticleIdList></Reference><Reference><Citation>Haick AK, Rzepka JP, Brandon E, Balemba OB, Miura TA. Neutrophils Are Needed for an Effective Immune Response Against Pulmonary Rat Coronavirus Infection, But Also Contribute to Pathology. J Gen Virol (2014) 95 578–90. doi: 10.1099/vir.0.061986-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.061986-0</ArticleId><ArticleId IdType="pmc">PMC4093780</ArticleId><ArticleId IdType="pubmed">24323639</ArticleId></ArticleIdList></Reference><Reference><Citation>Reusch N, de Domenico E, Bonaguro L, Schulte-Schrepping J, Baßler K, Schultze JL, et al. . Neutrophils in COVID-19. Front Immunol (2021) 12:652470. doi: 10.3389/fimmu.2021.652470</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.652470</ArticleId><ArticleId IdType="pmc">PMC8027077</ArticleId><ArticleId IdType="pubmed">33841435</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheemarla NR, Watkins TA, Mihaylova VT, Wang B, Zhao D, Wang G, et al. . Dynamic Innate Immune Response Determines Susceptibility to SARS-CoV-2 Infection and Early Replication Kinetics. J Exp Med (2021) 218:e20210583. doi: 10.1084/jem.20210583</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210583</ArticleId><ArticleId IdType="pmc">PMC8210587</ArticleId><ArticleId IdType="pubmed">34128960</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M, Alvarez C, Puhach O, Sattonnet-Roche P, Torriani G, Tapparel C, et al. . Sequential Infections With Rhinovirus and Influenza Modulate the Replicative Capacity of SARS-CoV-2 in the Upper Respiratory Tract. Emerg Microbes Infect (2022), 11:412–23. doi: 10.1080/22221751.2021.2021806</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.2021806</ArticleId><ArticleId IdType="pmc">PMC8803056</ArticleId><ArticleId IdType="pubmed">34931581</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig E, Fish EN. Distinct Signature Type I Interferon Responses are Determined by the Infecting Virus and the Target Cell. Antivir Ther (2008) 13:409–22. doi: 10.1177/135965350801300306</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/135965350801300306</ArticleId><ArticleId IdType="pubmed">18572754</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo SU, Kwon HJ, Ko HJ, Byun YH, Seong BL, Uematsu S, et al. . Type I Interferon Signaling Regulates Ly6C(hi) Monocytes and Neutrophils During Acute Viral Pneumonia in Mice. PloS Pathog (2011) 7:e1001304. doi: 10.1371/journal.ppat.1001304</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001304</ArticleId><ArticleId IdType="pmc">PMC3044702</ArticleId><ArticleId IdType="pubmed">21383977</ArticleId></ArticleIdList></Reference><Reference><Citation>Stifter SA, Bhattacharyya N, Pillay R, Florido M, Triccas JA, Britton WJ, et al. . Functional Interplay Between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation. PloS Pathog (2016) 12:e1005378. doi: 10.1371/journal.ppat.1005378</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005378</ArticleId><ArticleId IdType="pmc">PMC4701664</ArticleId><ArticleId IdType="pubmed">26731100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I Interferons Act Directly on CD8 T Cells to Allow Clonal Expansion and Memory Formation in Response to Viral Infection. J Exp Med (2005) 202:637–50. doi: 10.1084/jem.20050821</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20050821</ArticleId><ArticleId IdType="pmc">PMC2212878</ArticleId><ArticleId IdType="pubmed">16129706</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahm B, Trifilo MJ, Zuniga EI, Oldstone MBA. Viruses Evade the Immune System Through Type I Interferon-Mediated STAT2-Dependent, But STAT1-Independent, Signaling. Immunity (2005) 22:247–57. doi: 10.1016/J.IMMUNI.2005.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IMMUNI.2005.01.005</ArticleId><ArticleId IdType="pubmed">15723812</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang I, Scott JM, Kakarla T, Duriancik DM, Choi S, Cho C, et al. . Activation Mechanisms of Natural Killer Cells During Influenza Virus Infection. PloS One (2012) 7:e51858. doi: 10.1371/journal.pone.0051858</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051858</ArticleId><ArticleId IdType="pmc">PMC3534084</ArticleId><ArticleId IdType="pubmed">23300570</ArticleId></ArticleIdList></Reference><Reference><Citation>le Bon A, Thompson C, Kamphuis E, Durand V, Rossmann C, Kalinke U, et al. . Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN. J Immunol (2006) 176:2074–8. doi: 10.4049/jimmunol.176.4.2074</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.4.2074</ArticleId><ArticleId IdType="pubmed">16455962</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervantes-Barragan L, Kalinke U, Zust R, Konig M, Reizis B, Lopez-Macias C, et al. . Type I IFN-Mediated Protection of Macrophages and Dendritic Cells Secures Control of Murine Coronavirus Infection. J Immunol (2009) 182:1099–106. doi: 10.4049/jimmunol.182.2.1099</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.182.2.1099</ArticleId><ArticleId IdType="pubmed">19124753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma L, Peng X, Qing H, Hilliard BK, Kim J, Swaminathan A, et al. . Distinct Roles of Type I and Type III Interferons During a Native Murine Beta-Coronavirus Lung Infection. J Virol (2022) 96:e01241-21. doi: 10.1128/JVI.01241-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01241-21</ArticleId><ArticleId IdType="pmc">PMC8791255</ArticleId><ArticleId IdType="pubmed">34705554</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoner GD, Hallman M, Troxell MC. Lecithin Biosynthesis in a Clonal Line of Lung Adenoma Cells With Type II Alveolar Cell Properties. Exp Mol Pathol (1978) 29:102–14. doi: 10.1016/0014-4800(78)90030-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-4800(78)90030-8</ArticleId><ArticleId IdType="pubmed">581072</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Perlman S. Mouse Hepatitis Virus Does Not Induce Beta Interferon Synthesis and Does Not Inhibit its Induction by Double-Stranded RNA. J Virol (2007) 81:568–74. doi: 10.1128/JVI.01512-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01512-06</ArticleId><ArticleId IdType="pmc">PMC1797428</ArticleId><ArticleId IdType="pubmed">17079305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosert R, Kanjanahaluethai A, Egger D, Bienz K, Baker SC. RNA Replication of Mouse Hepatitis Virus Takes Place at Double-Membrane Vesicles. J Virol (2002) 76:3697–708. doi: 10.1128/jvi.76.8.3697-3708.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.8.3697-3708.2002</ArticleId><ArticleId IdType="pmc">PMC136101</ArticleId><ArticleId IdType="pubmed">11907209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G, Melia CE, Snijder EJ, Bárcena M. Double-Membrane Vesicles as Platforms for Viral Replication. Trends Microbiol (2020) 28:1022–33. doi: 10.1016/j.tim.2020.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7289118</ArticleId><ArticleId IdType="pubmed">32536523</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>